MBRX (MOLECULIN BIOTECH INC) — 2 tracked funds

Cross-fund · 2 holders

MBRX

MOLECULIN BIOTECH INC

CUSIP 60855D408

Tracked holders

$52,574

Aggregate value

16,035

Active funds

Funds holding MBRX

Fund	Strategy	Period	Value	% of book	Δ shares	Status
Vanguard	Institutional	Q4 2025	$51,450	—	+15,544	NEW
BlackRock	Institutional	Q1 2026	$1,124	—	−4	−0.8%
Citadel	Multi-Strategy	Q1 2026	—	—	−33,085	EXITED

Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.